| Elizabeth Jensen, APRN, DNP | |
|
120 Simsbury Rd Ste B, Avon, CT 06001-3735 | |
| (860) 674-0111 | |
| (860) 674-5406 |
| Full Name | Elizabeth Jensen |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Obstetrics & Gynecology |
| Location | 120 Simsbury Rd Ste B, Avon, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902912827 | NPI | - | NPPES |
| 004205440 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SW0102X | Clinical Nurse Specialist - Women's Health | 002310 (Connecticut) | Secondary |
| 363LX0001X | Nurse Practitioner - Obstetrics & Gynecology | 000189 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Jensen, APRN, DNP 120 Simsbury Rd Ste 12b, Avon, CT 06001-3735 Ph: (860) 674-0111 | Elizabeth Jensen, APRN, DNP 120 Simsbury Rd Ste B, Avon, CT 06001-3735 Ph: (860) 674-0111 |
News Archive
Many aspects of the German Genetic Diagnostics Act (Gendiagnostikgesetz) are out of touch with the latest technology, almost impossible to implement in clinical practice, or even detrimental to the success of recognised screening tests, such as newborn screening. The Act, which came into force in February 2010, is in desperate need of amendment.
The devastating, currently incurable motor-neuron disease spinal muscular atrophy might soon be treated with tiny, chemically modified pieces of RNA called antisense oligonucleotides.
Anacor Pharmaceuticals announced today that it will present a poster and oral presentation on a novel systemic anti-inflammatory candidate, AN6415, at the upcoming 8th Cytokines and Inflammation Conference, taking place January 28-29, 2010 in La Jolla, California.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
› Verified 4 days ago
Sasha Perry, PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Deborah L Collins-perrica, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 Fax: 860-284-6804 | |
Latonya Sheriee King, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 152 Simsbury Rd Bldg 9, Avon, CT 06001 Phone: 802-565-1755 Fax: 860-650-1920 | |
Courtney Streeto, APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-284-0182 | |
Marjorie Arni, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-674-2691 Fax: 860-677-6443 | |
Mr. David Yarbrough, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 385 W Main St, Avon, CT 06001 Phone: 860-777-1280 | |
Debra Anne Gage, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 80 Fisher Drive, Hartford Hospital Cancer Center, Avon, CT 06001 Phone: 860-674-0088 |